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Abstract
Background: Axon-guidance proteins play a crucial role in brain development. As the dysfunction of axon-
guidance signaling is thought to underlie the microstructural abnormalities of the brain in people with autism, we
examined the postmortem brains of people with autism to identify any changes in the expression of axon-
guidance proteins.
Results: The mRNA and protein expression of axon-guidance proteins, including ephrin (EFN)A4, eEFNB3, plexin
(PLXN)A4, roundabout 2 (ROBO)2 and ROBO3, were examined in the anterior cingulate cortex and primary motor
cortex of autistic brains (n = 8 and n = 7, respectively) and control brains (n = 13 and n = 8, respectively) using
real-time reverse-transcriptase PCR (RT-PCR) and western blotting. Real-time RT-PCR revealed that the relative
expression levels of EFNB3, PLXNA4A and ROBO2 were significantly lower in the autistic group than in the control
group. The protein levels of these three genes were further analyzed by western blotting, which showed that the
immunoreactive values for PLXNA4 and ROBO2, but not for EFNB3, were significantly reduced in the ACC of the
autistic brains compared with control brains.
Conclusions: In this study, we found decreased expression of axon-guidance proteins such as PLXNA4 and ROBO2
in the brains of people with autism, and suggest that dysfunctional axon-guidance protein expression may play an
important role in the pathophysiology of autism.
Introduction
Autism is a pervasive developmental disorder character-
ized by impairments in reciprocal social interactions and
communication, and the presence of repetitive and stereo-
typed behaviors [1]. Emerging evidence from neuroima-
ging studies suggests that there are abnormalities of
growth, microstructure and neuronal connectivity in the
brains of people with autism. For example, using magnetic
resonance imaging (MRI) with a diffusion tensor imaging
(DTI) technique, Barnea-Goraly et al. showed reduced
fractional anisotropy (FA), which is indicative of white-
matter structural alterations, in the anterior cingulate cor-
tex (ACC) of people with autism, a region known to be
related to social cognition [2]. This finding suggests that
impaired structural integrity in the white matter may play
an important role in the pathophysiology of autism.
Because autistic symptoms begin in the first years of life
and brain-growth abnormalities precede the onset of these
symptoms, it has been suggested that the microstructural
changes in the brain persist from the early developmental
stage [3].
At the cellular level, the growing neuronal cells during
brain development express receptors for families of axon-
guidance molecules, such as netrins, slits, ephrins and
semaphorins, at the growth cone. Activation of these
receptor signals, called ‘guidance cues’, navigates the out-
growth of axons, playing a key role in brain development
[4]. Several lines of evidence have shown that disruptions
of these guidance cues lead to malformation of the corpus
callosum and failure of neuronal projection [5].
Because the dysfunction of axon-guidance signaling is
thought to be related to microstructural abnormalities in
the brain of people with autism, as shown by neuroima-
ging studies, we examined the postmortem brains of
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sion of axon-guidance proteins.
Methods
Axon-guidance genes
We examined the postmortem brains of people with
autism to identify any differential expressions of axon-
guidance receptors, including (EFN)A4, eEFNB3, plexin
(PLXN)A4, roundabout 2 (ROBO)2 and ROBO3. These
candidate genes were selected because EFNA4, EFNB3
and PLXNA4 are located at autism-linked chromosome
loci [6], ROBO2 expression was reported to be reduced
in peripheral lymphocytes in people with autism [7], and,
in a case-control genetic-association study, ROBO3 was
linked with autism [7].
Human postmortem brain samples
All experimental procedures were approved by the Insti-
tutional Review Board of Hamamatsu University School
of Medicine. Tissue samples were obtained from the
Autism Tissue Program (Princeton, NJ) and NICHD
Brain and Tissue Bank for Developmental Disorders
(Baltimore, MD).
The samples obtained were frozen postmortem sam-
ples of human left ACC (Brodmann area 24, ventral
region), a region implicated in the pathophysiology of
autism (that is,, the functional alteration of the region is
correlated with severity of autistic symptoms) [8-10],
taken from people with autism (n = 8) and age-matched
controls (n = 13), and frozen postmortem samples of
human primary motor cortex (PMC) (Brodmann area 4),
which has been shown to exhibit no functional difference
between people with autism and controls, taken from
people with autism (n = 7) and age-matched controls
(n = 8). The autism and control samples were further
matched for gender and the postmortem interval (PMI)
(Table 1). The diagnosis of autism was made according
to the Diagnostic and Statistical Manual, Fourth Edition,
Text Revision, and confirmed by the Autism Diagnostic
Interview-Revised.
Real-time quantitative reverse-transcriptase polymerase
chain reaction
Differential expression of candidate genes was investi-
gated by real-time reverse-transcriptase (RT)-PCR as
described elsewhere [11], carried out in a fast real-time
PCR system (ABI PRISM 7900HT; Applied Biosystems,
Foster City, CA, USA) using Taqman probe detection,
following the manufacturer’s recommendations.
For the analysis of plexin A4, two isoforms (plexin
A4A and plexin A4B) were tested. The expression of
either gene relative to each of three internal control
housekeeping genes (ß-actin, glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) and ß2-microglobin)
was determined as 2
-ΔCt, and normalized by the mean
value of the controls.
Western blotting
The protein levels of differentially expressed genes were
further analyzed by western blotting as described pre-
viously [12]. Briefly, 40 μg of each brain sample was
loaded onto a 7.5% SDS polyacrylamide gel and separated
by electrophoresis. The proteins were electroblotted onto
a polyvinylidene fluoride membrane (Millipore, Billerica,
MA, USA), then blocked and incubated with the primary
antibody at 4°C overnight, followed by incubation with a
horseradish peroxidase-conjugated secondary antibody.
The primary antibodies used were anti-ROBO2 (1:1000;
R & DS y s t e m s ,M i n n e a p o l i s ,M N ,U S A ) ,a n t i - E F N B 3
(1:500; R&D Systems), anti-PLXNA4 (1:500; Abcam,
Cambridge, Cambridgeshire, UK) and anti-ß-actin
(1:2000; Abcam). The densities of the immunoreactive
bands were quantified and analyzed using Image-J soft-
ware http://rsbweb.nih.gov/ij/.
Statistical analysis
For the real-time PCR analysis, the resultant data had a
non-normal distribution, thus the statistical analysis was
conducted using the Mann-Whitney U-test. Because of
the complexity of using three housekeeping genes as a
reference, we considered a finding to be significant when
the relative expression of the relevant candidate gene was
significantly different at the P < 0.05 level from all three
housekeeping genes. Thus, the significant results in our
real-time RT-PCR analyses can be viewed as conservative.
For western blotting, he protein expression level of each
enzyme was normalized by the level of ß-actin. The two-
tailed unpaired t-test was used, and values of P <0 . 0 5
were considered significant.
Results
There was no significant difference in age (t = 0.16,
degrees of freedom (d.f.) = 19, P = 0.88; t = 0.39, d.f. =
13, P = 0.70), PMI (t = 0.67, d.f. = 18, P = 0.51; t = 0.13,
d.f. = 12, P = 0.90) or gender (P=1.0; P=1.0, Fisher’s
Table 1 Summary of demographic variables on brain
samples
Variable Control, n = 13 Autism, n = 8 P-value
Age, years
a 15.6 ± 6.5 (8 to 28) 16.4 ± 8.3 (8 to 29) 0.818
b
Gender, n (%) 1.0
c
Male 9 (69) 6 (75)
Female 4 (31) 2 (25)
PMI, hours
a, d 15.0 ± 5.6 (5 to 22) 18.0 ± 14.5 (9 to 50) 0.509
b
aMean ± SD (range).
bDerived from two-tailed unpaired t-test.
cDerived from Fisher’s exact test.
dPMI, postmortem interval.
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Figure 1 Differential mRNA and protein expression of each candidate molecule. (A) Differential mRNA expression of EFNB3, PLXNA4A and
ROBO2 in the anterior cingulate cortex (ACC) of brains from people with autism and controls. Graphs represent the mean ratio (autism:control)
of relative expression levels. The error bar represents the SEM. There were thirteen control and eight autistic samples. *P < 0.05, **P < 0.01, ***P
< 0.001 by Mann-Whitney U-test. Left to right, U =4 ,P < 0.001; U = 18, P = 0.015; U = 0., P < 0.001; U = 11, P < 0.003; U = 14, P < 0.007; U =3 ,
P < 0.001; U =7 ,P < 0.001; U = 23, P < 0.039; U = 0., P < 0.001. (B) Western blots showing the immunolabeling of PLXNA4 and ROBO2 in the
ACC of control and autistic samples. (C) The values in the graphs are the mean percentage of the mean of the control values. There were
thirteen control and eight autistic samples. *P < 0.05 by two-tailed unpaired t-test. Left to right, t = 2.44, df = 19, P < 0.024; t = 2.14, df = 19, P <
0.045.
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(ACC and PMC, respectively).
Real-time RT-PCR revealed that the relative expression
levels of EFNB3, PLXNA4A and ROBO2, compared, with
all three housekeeping genes were significantly lower in
the ACC of people with autism than in the ACC of con-
trols. The other axon-guidance signaling-related genes we
examined (EFNA4, PLXNA4B and ROBO3), did not meet
our stringent criteria for significance (Figure 1A). In addi-
tion, none of the genes tested in the study had significantly
different expression in the PMC of autistic brains com-
pared with the PMC of control brains.
The protein levels of the three genes that were shown by
real-time RT-PCR to be differentially expressed in the
ACC of autistic brains (that is,, EFNB3, PLXNA4A and
ROBO2) were further examined using western blotting.
The immunoreactive levels of PLXNA4 and ROBO2 were
significantly reduced in the ACC of the autistic compared
with that of the control brains, with a 53.0% reduction for
PLXNA4 (t =- 2 . 4 4 ,d . f .=1 9 ,P < 0.05) and, a 53.4% reduc-
tion for ROBO2 (t = -2.14, d.f. = 19, P < 0.05) in the aut-
ism group relative to the control group (Figure 1B, C).
However, the value of EFNB3 was not significantly differ-
ent between the two groups (t =1 . 4 3 ,df = 19, P = 0.17).
We then examined the correlations between the mRNA/
protein levels of the genes and the age, PMI or gender of
the subjects, and found no significant difference.
Discussion
In this study, we investigated the transcriptional and trans-
lational regulation of axon-guidance receptors in the ACC
of people with autism. The results provide the first evi-
dence, to our knowledge, of reduced mRNA and protein
levels of axon-guidance receptors, including those of
PLXNA4 and ROBO2, in the ACC of people with autism;
this region has previously been implicated in the pathophy-
siology of autism. We found a downregulation of both
types of receptors in the ACC, although such downregula-
tion was not evident in the other region examined, the
PMC.
PLXNA4 is a multiple semaphorin (Sema) receptor
that mediates axon-repulsive signaling. Animal studies
have shown that a disruption of PLXNA4/Sema signal-
ing causes a malformation of white matter, such as the
anterior commissure [13]. By contrast, ROBO2 is a
receptor for Slit proteins, which are crucial for the
proper development of forebrain connections. It is of
particular interest that a loss of ROBO2/Slit function
affects development of the serotonergic and dopaminer-
gic systems [5], both of which are implicated in the
pathophysiology of autism.
Our results regarding the altered regulation of axon-gui-
dance receptors in the brains of autistic people, together
with the finding that a loss of function of axon-guidance
proteins elicits abnormalities of white-matter formation
and axonal trajectory, are in line with findings from recent
neuroimaging studies showing abnormalities of micro-
structure and neuronal connectivity in the brains of people
with autism. For example, DTI studies showed reduced FA
(that is,, impaired structural integrity) in white matter in
the region of the ACC in people with autism [9]. However,
to clarify the association between structural abnormalities
and axon-guidance proteins in autism, further studies con-
ducting both neuroimaging and relevant genetic analyses
in the same individuals with the disorder will be necessary.
In addition, recent microarray analyses of a genetic
mouse model for Smith-Lemli-Opitz Syndrome, which
is characterized by mental retardation and multiple con-
genital anomalies with the behavioral features of autism,
displayed dynamic gene-expression changes in axonal-
guidance proteins in the brain [14]. Furthermore, recent
studies have suggested positive associations of genes
involved in the plexin/semaphorin signaling system and
schizophrenia [15,16], which overlaps with autism in
certain area of social dysfunction [17]. The findings of
these studies, together with our results, suggest that
abnormalities of axon-guidance proteins may be directly
linked to the behavioral symptoms characteristic of
autism.
Because the present study was limited by the small
sample size, a larger sample size would bolster our find-
ings. However, we used conservative statistical proce-
dures to avoid type I error (three housekeeping genes
were used as reference), along with western-blotting
analysis to confirm the results. Therefore, our findings
can be considered as evidence that axon-guidance pro-
teins play an important role in the pathophysiology of
autism.
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